系统性血管炎.ppt

第64页,共68页，5月，星期六，2024年，5月ReferenceNumberofpatientsGlucocorticoidsbefore(mg/day)Glucocorticoidsduring(mg/day)Improvementonvascularimaging,modalityRelapseafterdiscontinuation,intervalSalvarani112.52.5Yes,PET/CT1of1,5monthsSeitzetal.319–Yes,MRA,n=1–Sciascia225–––Beyeretal.330***7.5Yes,PET/CT,n=2–Vinitetal.120–of1,6monthsUnizonyetal.725.52.2–of1,2monthsBesadaandNossent12010Yes,MRIandUSof1,2monthsChristidisetal.1203.5Yes,PET/CT–IL-6单抗：难治性GCA第65页,共68页，5月，星期六，2024年，5月ReferencenGCsbefore(mg/day)GCsduring(mg/day)ImprovementonvascularimagingRelapseafterdiscontinuationNishimoto1307.5Yes,CT–Salvarani20–12.50Yes,PET/CT,n=20of2Seitz237.56Yes,MRA,n=2duringtreatmentUnizony2110.9Yes,PET/CT,n=1–Bredemei1305No,CTof1,3monthsSalvarani112.50Yes,PET/CTof1,2monthsIL-6单抗：难治性TA第66页,共68页，5月，星期六，2024年，5月Diseaseactivity(BVAS)8/10achievedremissionon7.5mgpred/d.NorelapsesonMepolizumabStoppedMep,7/8relapsesw/in10months抗IL-5(Mepolizumab)治疗EGPA（CSS）：KimSetal.JAllergyClinImmunol2010;125:1336-43第67页,共68页，5月，星期六，2024年，5月感谢大家观看第68页,共68页，5月，星期六，2024年，5月*Note：FDG:氟代脱氧葡萄糖PrevAbstract#:2362NextAbstractSubmissionsACREvaluationofDiseaseActivityUsingFDGPET-CTinPatientswithLargeVesselVasculitisPresenter:GiuliaPazzola:ArcispedaleSMariaNuova,IRCCSDate:Tuesday,November13Time:9:00AM-6:00PM

Location:PosterHall(HallB)SessionTitle:VasculitisCategory:Vasculitisvasculitis,diagnosticimagingKeywords:vasculitis,diagnosticimagingSavetoMyItinerarySubmitEvaluationUnavailableBackground/Purpose:18F-Fluorodeoxyglucose(FDG)positronemissiontomography(PET)/computerizedtomography(CT)[PET/CT]hasbeenproposedasausefultooltodiagnoseandmonitoractivityoflargevesselvasculitis(LVV),butitspreciseroleremainsde